198 related articles for article (PubMed ID: 28406767)
41. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
42. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q
Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.
DeUgarte CM; Bartolucci AA; Azziz R
Fertil Steril; 2005 May; 83(5):1454-60. PubMed ID: 15866584
[TBL] [Abstract][Full Text] [Related]
44. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
[TBL] [Abstract][Full Text] [Related]
45. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
46. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.
Caglar GS; Kahyaoglu I; Pabuccu R; Demirtas S; Seker R
Arch Gynecol Obstet; 2013 Oct; 288(4):905-10. PubMed ID: 23553200
[TBL] [Abstract][Full Text] [Related]
47. Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.
Alebić MŠ; Bulum T; Stojanović N; Duvnjak L
Endocrine; 2014 Nov; 47(2):625-30. PubMed ID: 24522614
[TBL] [Abstract][Full Text] [Related]
48. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.
Kucukaydın Z; Duran C; Basaran M; Camlica F; Erdem SS; Basaran A; Kutlu O; Burnik FS; Elmas H; Gonen MS
J Endocrinol Invest; 2016 Oct; 39(10):1139-48. PubMed ID: 27300033
[TBL] [Abstract][Full Text] [Related]
49. Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome.
Sawada M; Masuyama H; Hayata K; Kamada Y; Nakamura K; Hiramatsu Y
Endocr J; 2015; 62(11):1017-23. PubMed ID: 26370557
[TBL] [Abstract][Full Text] [Related]
50. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
Kurioka H; Takahashi K; Miyazaki K
Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
[TBL] [Abstract][Full Text] [Related]
51. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
Calvar CE; Bengolea SV; Hermes R; Loyato M
Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
[TBL] [Abstract][Full Text] [Related]
52. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
[TBL] [Abstract][Full Text] [Related]
53. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
54. Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women.
Jahromi BN; Dabbaghmanesh MH; Bakhshaie P; Parsanezhad ME; Anvar Z; Alborzi M; Zarei A; Bakhshaei M
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):555-559. PubMed ID: 30122578
[TBL] [Abstract][Full Text] [Related]
55. Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome.
Rizzo M; Tyndall EK; Frontoni S; Jacoangeli F; Sarlo F; Panebianco F; Mistorni A; Di Renzo L; Calafiore R; Luca G; De Lorenzo A
J Endocrinol Invest; 2013; 36(7):527-30. PubMed ID: 23612476
[TBL] [Abstract][Full Text] [Related]
56. Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome.
Möhlig M; Spranger J; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Moltz L; Brabant G; Schöfl C
Eur J Endocrinol; 2006 Feb; 154(2):295-301. PubMed ID: 16452544
[TBL] [Abstract][Full Text] [Related]
57. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.
Douglas CC; Norris LE; Oster RA; Darnell BE; Azziz R; Gower BA
Fertil Steril; 2006 Aug; 86(2):411-7. PubMed ID: 16762348
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
[TBL] [Abstract][Full Text] [Related]
59. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
Alemzadeh R; Kichler J; Calhoun M
Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
[TBL] [Abstract][Full Text] [Related]
60. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
Ezeh U; Arzumanyan Z; Lizneva D; Mathur R; Chen YH; Boston RC; Chen YI; Azziz R
Hum Reprod; 2019 Feb; 34(2):335-344. PubMed ID: 30576500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
